Recruiting NCT06463756
AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma
Laryngeal Carcinoma · Thyroid Cartilage
CAR-T & cell therapy
1,352 trials in this section
Recruiting NCT05255354
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
Follicular Lymphoma · Diffuse Large B Cell Lymphoma · Mantle Cell Lymphoma
Not yet recruiting NCT06567366
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
Large B-cell Lymphoma
Recruiting NCT06479356
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Non-Hodgkin Lymphoma · Large B-cell Lymphoma
Recruiting NCT06560827
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
HCC
Recruiting NCT06414135
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Systemic Sclerosis
Recruiting NCT06544720
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
Human Papillomavirus Associated Carcinomas · Cervical Cancer · Head and Neck Cancers
Not yet recruiting NCT06545201
RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors
KRAS G12V · T Cell Therapy
Recruiting NCT06006390
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
Gastric Cancer · Colon Cancer · Rectal Cancer
Recruiting NCT06525545
Early MOtion Total Ankle Artroplasty
Ankle Osteoarthritis · Ankle - Recurrent Dislocation · Cartilage Disease
Not yet recruiting NCT06519344
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
B Cell Malignancies
Not yet recruiting NCT06518876
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome
POEMS Syndrome
Recruiting NCT06515262
Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
Relapsed/Refractory Multiple Myeloma
Recruiting NCT06352281
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
ITP - Immune Thrombocytopenia
Not yet recruiting NCT06505551
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
HPV-Related Squamous Cell Carcinoma · HPV-Related Cervical Squamous Cell Carcinoma · HPV-Related Vulvar Squamous Cell Carcinoma
Recruiting NCT06503107
Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM
Multiple Myeloma
Recruiting NCT06492798
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Long COVID · Post-Acute COVID-19 Syndrome
Recruiting NCT06487377
IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations
Pancreatic Cancer · Colorectal Cancer
Recruiting NCT02445534
Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Cardiomyopathy, Dilated
Recruiting NCT06482684
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
Mantle Cell Lymphoma
Recruiting NCT06478225
Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer
Tumor Pancreas
Recruiting NCT06196294
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Pancreas Cancer · Lung Cancer · Liver Cancer
Recruiting NCT05779917
Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers
Pancreas Cancer · CAR-T Cell Therapy · Mesothelin
Recruiting NCT05341492
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
EGFR/ B7H3-positive Advanced Lung Cancer · EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
Recruiting NCT05060796
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLC
Non Small Cell Lung Cancer
Recruiting NCT04842812
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
Liver Cancer · Lung Cancer · Breast Cancer
Recruiting NCT03198052
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
Lung Cancer · Cancer · Immunotherapy
Recruiting NCT03778814
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
Nonsmall Cell Lung Cancer · Solid Tumor, Adult
Recruiting NCT05410717
CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
Stage IV Ovarian Cancer · Testis Cancer, Refractory · Endometrial Cancer Recurrent
Recruiting NCT03198546
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Hepatocellular Carcinoma · Immunotherapy · CAR
Not yet recruiting NCT06373991
A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Recruiting NCT06462248
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
Lymphoma, Nonhodgkin · Leukemia, Lymphocytic
Not yet recruiting NCT06454890
Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer NSCLC
Recruiting NCT06445803
CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia With Failed Remission · B-cell Lymphoma Refractory
Recruiting NCT06439173
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Diffuse Large B Cell Lymphoma
Recruiting NCT06182696
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
Relapsed and/or Refractory Multiple Myeloma
Not yet recruiting NCT06420154
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
Systemic Lupus Erythematosus (SLE) · Sjogren's Syndrome · Systemic Sclerosis
Recruiting NCT06346912
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic Leukemia,B-Cell · Non-hodgkin Lymphoma,B Cell
Recruiting NCT05693844
Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors
Recruiting NCT06400862
Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue
Traumatic Cartilage Injury
Not yet recruiting NCT06384469
The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolism
Rhinoplasty · Nasal Skin-soft Tissue Envelope Metabolism · Lactic Acid
Not yet recruiting NCT06383507
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Metastatic Tumor · Advanced Solid Tumor · Renal Cell Carcinoma
Recruiting NCT06375161
Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
B Cell Malignancies
Recruiting NCT06367673
Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia
AML, Adult
Not yet recruiting NCT06369935
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
Relapsed/Refractory Multiple Myeloma
Recruiting NCT06087341
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
Advanced Sarcoma
Recruiting NCT05577091
Tris-CAR-T Cell Therapy for Recurrent Glioblastoma
Recurrent Glioblastoma
Not yet recruiting NCT06358053
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
Cervical Cancer · Anal Cancer · Head and Neck Cancers
Recruiting NCT06279923
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
Autoimmune Diseases
Recruiting NCT06355739
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
B Lymphocytic Leukemia · B Lymphoblastic Lymphoma
Recruiting NCT05652920
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
Hepatocellular Carcinoma
Recruiting NCT06339255
Italian Observational Study on CAR-T Therapy for Lymphoma
Diffuse Low Grade B-Cell Lymphoma · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Mantle Cell Lymphoma
Recruiting NCT06333275
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy
Vaccine Immunity in CAR-T Cell Therapy Recipients
Not yet recruiting NCT06333509
Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
Multiple Myeloma · Primary Plasma Cell Leukemia
Recruiting NCT06327997
An Exploratory Study by Fast CAR T Cells
Solid Tumor
Recruiting NCT06321289
Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL
Non-hodgkin Lymphoma,B Cell
Recruiting NCT06249906
Efficacy of Bioceramic Materials for Bone Defects Repair
Bone Lesion · Cartilage Degeneration · Osteo Arthritis Knee
Not yet recruiting NCT06298266
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Not yet recruiting NCT06298591
The Efficacy of Combination Therapy in Atrophic Scars
Atrophic Scar
Recruiting NCT06101082
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
Solid Tumor
Recruiting NCT05312775
Niche In CEsarean Scar Trial (NICEST)
Niche
Recruiting NCT06277427
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Lupus Nephritis · ANCA Associated Vasculitis
Recruiting NCT06013111
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors
Carcinoma
Recruiting NCT06249256
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Solid Tumor
Recruiting NCT06247501
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation
Very High Risk Acute Lymphoblastic Leukemia · CD19 CAR-T Therapy
Recruiting NCT06248697
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Solid Tumor
Recruiting NCT05243212
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
Multiple Myeloma · Relapse Multiple Myeloma
Not yet recruiting NCT06220539
CAsting and REhabilitation Versus Supervised Neglect for Osteochondral Lesions of the Talus in the Pediatric Population
Cartilage Injury · Orthopedic Disorder · Skeletal Injury
Recruiting NCT06215950
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Ovarian Cancer · Cervix Cancer · Metastatic Cancer
Not yet recruiting NCT06196658
Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer
Pancreatic Cancer · Advanced Biliary Cancer
Recruiting NCT06196255
Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
Multiple Myeloma
Recruiting NCT06180174
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
B Cell Lymphoma · Non Hodgkin Lymphoma
Recruiting NCT06170294
MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors
Advanced Solid Tumor
Recruiting NCT05681650
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
HER2 Positive Advanced Solid Tumors
Recruiting NCT04729543
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Melanoma · Melanoma, Uveal · Head and Neck Cancer
Not yet recruiting NCT06142188
Relmacabtagene Autoleucel in Hematologic Malignancies
Lymphoma, B-Cell · Large B-cell Lymphoma · Follicular Lymphoma
Recruiting NCT06136364
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
T-lymphoblastic Lymphoma · T-ALL
Recruiting NCT06135922
Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
EBV-associated Hemophagocytic Lymphohistiocytosis · EBV Infection
Not yet recruiting NCT06134960
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
Gastric Cancer · Pancreatic Cancer · Solid Tumor
Recruiting NCT06132711
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
Multiple Myeloma
Recruiting NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors
Gastric Cancer · Colon Cancer · Rectal Cancer
Recruiting NCT06125652
Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)
Acute Myeloid Leukemia Refractory · Acute Myeloid Leukemia, in Relapse
Recruiting NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
Gastric Cancer · Colon Cancer · Pancreas Cancer
Recruiting NCT06010875
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Renal Cell Carcinoma · Ovarian Cancer · Cervix Cancer
Recruiting NCT06084962
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Recruiting NCT06081478
CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia · B-cell Lymphoma · Diffuse Large B Cell Lymphoma
Recruiting NCT06072989
Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors
Advanced Solid Tumor
Recruiting NCT06056921
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
SLE (Systemic Lupus) · Sjogren's Syndrome · Systemic Scleroderma
Recruiting NCT06044506
Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma
Hepatocellular Carcinoma
Recruiting NCT06045091
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
Multiple Myeloma · Plasma Cell Leukemia
Recruiting NCT06043466
A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Colorectal Cancer · Esophagus Cancer · Gastric Cancer
Recruiting NCT05544526
CAR T Cells to Target GD2 for DMG
Diffuse Midline Glioma, H3 K27M-Mutant
Recruiting NCT06027853
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
AML, Adult
Recruiting NCT05942430
Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions
Articular Cartilage Defect
Recruiting NCT04744402
Phase 2 Clinical Trial of CartiLife® in the United States
Articular Cartilage Defect · Articular Cartilage Degeneration
Not yet recruiting NCT04729582
Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients
Urinary Incontinence · Epispadias, Male
Recruiting NCT03570450
Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
Stroke
Recruiting NCT05951517
Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
Henoch-Schönlein Purpura · Gastrointestinal Injury · Mycophenolate Mofetil
Recruiting NCT05947487
CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors
Solid Tumor, Adult
Recruiting NCT05948033
CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma
Lymphoma